The $200 million plus round brings together lead investor AON ConsultingInc.with prominent investors such as NFL legend and eMed Founding Chief Wellness Officer Tom Bradyalongside Jeff AroninFounderChairman and CEO of Paragon Biosciences; Ara CohenCo-Founder and Co-Managing Member of Knighthead Capital Management; Antonio GraciasFounder and CEO of Valor Equity Partners; Joe LonsdaleFounder and Managing Partner at 8VC and Co-Founder of Palantir; R.J. MelmanCEOLettuce Entertain You Restaurants; Tom RickettsChairman of the Chicago Cubs; and former X CEO and current eMed CEO Linda Yaccarino.

eMed is the gold standard in clinically managed GLP-1 programs for employers. At the core is a fundamental reality: GLP-1s are among the most significant therapeutic advances of our timebut their impact is only realized when patients stay on treatment. By achieving more than 90% member adherencemore than double the industry normeMed's program delivers what others cannot: employees who stay the course and see real resultsincluding an average weight loss of 21 poundswith 99% seeing improvement in at least one key biomarker within six months.